Financiere de Tubize SA (TUB.BR) stock: key figures, P/E, revenue and dividend
Health Care · Belgium · ISIN BE0003823409
Price
172.80 EUR
Market cap
7.69 bn EUR
P/E (2025)
82.51
P/S (2025)
–
Dividend yield
0.63 %
Net margin
–
Return on equity (ROE)
4.94 %
Return on assets (ROA)
4.82 %
Financiere de Tubize SA financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 EUR | – |
| Gross profit | -2.00 m EUR | – |
| Operating income | -2.24 m EUR | -2.97 m EUR |
| EBIT | -2.00 m EUR | – |
| Net income | 90.00 m EUR | 93.23 m EUR |
| Diluted EPS – continuing operations | 2.00 EUR | 2.09 EUR |
Full history since 1995, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Financiere de Tubize SA
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.
More stocks
- Shanghai International Airport Co Ltd (600009.SS)
- Fukuoka Financial Group Inc (8354.T)
- Kingsemi Co Ltd (688037.SS)
- Toppan Printing Ltd (TOPPY)
- CareTrust REIT, Inc. (CTRE)
- Caris Life Sciences, Inc. (CAI)
- InPost SA (INPST.AS)
- Shenzhen Fastprint Circuit Tech Co Ltd (002436.SZ)
- CYTOKINETICS INC (CYTK)
- 360 Security Technology Inc (601360.SS)
- ITEQ Corp (6213.TW)
- CIG ShangHai Co Ltd Class A (603083.SS)
Not investment advice. All data without warranty, price as of 16.10.2026. Details in the risk notice.